Market cap
₹83 Cr
Recently Viewed
Clear AllBSE: 506919
₹141.05
₹-0.45
(-0.32%)
As on 30-Apr-2026IST
Market cap
₹83 Cr
Revenue (TTM)
₹139 Cr
P/E Ratio
68.6
P/B Ratio
1.1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹1 Cr
ROE
16.3 %
ROCE
19 %
Industry P/E
29.51
EV/EBITDA
6.5
Debt to Equity
0
Book Value
₹123.8
EPS
₹2
Face value
10
Shares outstanding
5,900,376
CFO
₹26.18 Cr
EBITDA
₹58.56 Cr
Net Profit
₹28.36 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Makers Lab
| 19.4 | -3.1 | 17.6 | -1.4 | 8.1 | -9.9 | 8.4 |
|
BSE Healthcare
| 2.7 | 6.8 | 7.9 | 5.7 | 24.7 | 13.8 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Makers Lab
| -39.0 | 25.2 | 14.4 | -35.4 | -34.4 | 677.8 | -42.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Makers Lab
|
141.1 | 83.2 | 138.8 | 5.9 | 5.9 | 1.7 | 68.6 | 1.1 |
| 2,822.7 | 35,289.3 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.8 | 7.7 | |
| 8,213.0 | 20,543.0 | 2,177.5 | 200.9 | 11.3 | 26.5 | 102.3 | 24.7 | |
| 1,709.0 | 13,002.6 | 2,089.5 | 622.0 | 31.3 | 20.4 | 21.2 | 3.9 | |
| 1,726.6 | 10,550.1 | 1,196.4 | 149.4 | -- | 27.5 | 70.6 | 15.1 | |
| 1,322.9 | 18,325.8 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.4 | 5.1 | |
| 2,043.4 | 32,884.0 | 4,193.0 | 753.8 | 22.7 | 20.8 | 43.6 | 8.2 | |
| 4,710.6 | 21,538.7 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.2 | 5.4 | |
| 5,216.9 | 8,622.6 | 1,348.5 | 293.5 | 28.1 | 50.7 | 29.4 | 12.4 | |
| 1,036.8 | 9,552.3 | 4,725.6 | 528.7 | 14.9 | 20.7 | 18.7 | 3.2 |
No Review & Analysis are available.
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. The company offers products in general health therapeutic segments, including acid regulatory, anthelmintic, anti-allergic,... anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeal, anti-emetics and anti-nauseants, anti-fungal, anti?inflammatory, analgesic, anti-spasmodic, anti-malarial, anti-thyroid, cough and cold control, digestives, neurotonic, nutritional supplements, topical anti-biotic/anti-microbial, and other specialties. It also provides diabetic and hypertensive drugs. The company's principal formulation brands comprise Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin. It serves approximately 1,500 stockiests'; 1,00,000 doctors; and 2,00,000 retailers through a distribution network of 20 consignment agents and 15 super stockiests'. The company was incorporated in 1984 and is based in Mumbai, India. Read more
Incorporated
1984
Chairman
R K P Verma
Managing Director
--
Group
Ipca Laboratories
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Makers Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Makers Laboratories Ltd is ₹141.05 (BSE) as of 30-Apr-2026 IST. Makers Laboratories Ltd has given a return of 8.1% in the last 3 years.
The P/E ratio of Makers Laboratories Ltd is 68.55 times as on 30-Apr-2026, a 132 premium to its peers’ median range of 29.51 times.
The P/B ratio of Makers Laboratories Ltd is 1.14 times as on 30-Apr-2026, a 75 discount to its peers’ median range of 4.56 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
10.16
|
1.08
|
|
2024
|
0.00
|
1.05
|
|
2023
|
0.00
|
0.83
|
|
2022
|
18.03
|
1.51
|
|
2021
|
0.00
|
2.17
|
The 52-week high and low of Makers Laboratories Ltd are Rs 173.70 and Rs 109.00 as of 30-Apr-2026.
Makers Laboratories Ltd has a market capitalisation of ₹ 83 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Makers Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.